1996
DOI: 10.1016/0031-9384(95)02272-4
|View full text |Cite
|
Sign up to set email alerts
|

Sexual behavior in male rats after nitric oxide synthesis inhibition

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
36
0

Year Published

1997
1997
2014
2014

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 48 publications
(36 citation statements)
references
References 26 publications
0
36
0
Order By: Relevance
“…Thus, although NO appears to be important for the initial acquisition of copulatory behavior, it may not be an absolute requirement for its maintenance. However, even sexually experienced rats in this and other studies have shown sexual deficits with systemically (Benelli et al, 1995;Bialy et al, 1996;Hull et al, 1994) or centrally (Melis et al, 1998;Sato et al, 1998Sato et al, , 1999 administered NOS inhibitors.…”
Section: Discussionmentioning
confidence: 45%
“…Thus, although NO appears to be important for the initial acquisition of copulatory behavior, it may not be an absolute requirement for its maintenance. However, even sexually experienced rats in this and other studies have shown sexual deficits with systemically (Benelli et al, 1995;Bialy et al, 1996;Hull et al, 1994) or centrally (Melis et al, 1998;Sato et al, 1998Sato et al, , 1999 administered NOS inhibitors.…”
Section: Discussionmentioning
confidence: 45%
“…Benelli et al, 1995;Bialy et al, 1996;Hull et al, 1994) nitric oxide (NO), in both basal and female-stimulated conditions (reviewed in Dominguez and Hull, 2005;Hull et al, 2006). NO synthase immunoreactivity (NOS-ir) is positively regulated by both T and E 2 (Du and Hull, 1999;Putnam et al, 2005).…”
Section: Ne Antagonists − (Clark and Smith 1990)mentioning
confidence: 99%
“…Both NO donors and PDE5-i's are known to reduce the contractile response of human SVs, 23 to reverse postsynaptic contraction of isolated human SV with different potency 24 and to inhibit seminal emissions in rats, 25 whereas NOS inhibitors, such as L-NAME, decrease the latency to emission. 26 It is noteworthy that not only the bladder neck, urethra and prostate but also the SV and VD show a typical mRNA distribution for a-adrenoceptors, 27 which accounts for by their capacity to delay or abolish ejaculation reported in clinical studies in men with prostatic hyperplasia (up to 7% of cases reported with tamsulosin). It is supposed that ejaculatory disorders caused by selective a 1 A-adrenoceptor antagonists are not a result of retrograde ejaculation but a loss of seminal emission (dry ejaculation).…”
Section: Introductionmentioning
confidence: 99%